Health news alert problems for newsroom editors

What to take away

Common health news alert problems often begin when a short rewrite drops the notice's qualifiers.

Why alerts break in the rewrite

A 900-word agency notice becomes a 40-word headline, and the qualifiers are what gets cut. The remaining sentence is grammatical and wrong.

The fixes below cover claims that can send a reader to the wrong product, the wrong place, or a medical action the issuer never recommended. Before writing, check the original notice for its exact scope, evidence, audience and current action.

Use the issuer's word, not a stronger one

Alert, report, investigation, advisory and recall carry different weights in every agency's vocabulary. Treating them as interchangeable turns a routine surveillance flag into an emergency.

Write "officials are investigating a cluster" when investigation is the known fact. Reserve crisis language for a source that applies it to this event, on the record.

A report is not proof

An adverse-event report, a complaint, or a case report shows that someone recorded something. It does not show what caused it.

Name the data type and where it sits in review. Ask whether there is a comparison group, a laboratory confirmation, exposure evidence, or a regulator's causality finding. Where sequence is all you have, "reported after" is the honest verb. The Health evidence and alert types compared article offers further context, but state the evidence type and stage of review in the alert itself.

The National Library of Medicine tells readers to check who runs a health site, its purpose, its original source, its review process, its update date and its privacy practices. The MedlinePlus guide to evaluating health information is built for tracing a claim back to its evidence rather than trusting a clean page.

Relative risk needs a floor under it

A 40 percent increase in a rare outcome can be a handful of cases. A case count without a denominator is a number with no size.

Give counts and denominators when the source does. State the baseline period and the follow-up period. Keep individual risk separate from a population estimate, and do not convert to "one in X" unless the study supports it. Put the numerator, denominator, population and comparison period beside the percentage before writing it; if the source omits one, say so rather than infer it. Economic desks fight the same shortcut; see Economic reporting problems: how to read releases.

Product scope is the first thing a headline drops

A headline names a brand. The notice covers one lot, one model, one size, one expiration window.

Field	What goes in it	Why it blocks publication

| Lot or batch code | Exact code shown on the notice and package | A different code may be outside the recall. | | Model | Exact model or serial range, when applicable | Similar models may not be affected. | | Size | Exact size or package variant, when applicable | A brand can include unaffected variants. | | Expiration window | Exact range listed in the notice, when applicable | Products outside the stated window may not be included. |

Compare the notice against label images before publishing. Record the exact lot, model, size and expiration window the notice names; mark a field not applicable when the notice does not specify it. If confusion is likely, put "not all products" in the opening line. The Health alert reporting checklist: what to confirm offers additional guidance on these publication-blocking fields.

Publicity is not a recall class

A company notice that travels far is still a company notice. A market withdrawal is not a recall.

State who initiated the action and when. Add a risk class only when the regulator lists one.

FDA's drug-recall risk classes mean different things: Class I indicates a reasonable probability of serious adverse health consequences or death; Class II indicates possible temporary or medically reversible consequences, or a remote probability of serious consequences; Class III means serious adverse health consequences are not likely. Use a class only when FDA assigns it; do not infer one from a company's wording or the notice's visibility. FDA's general recall framework, including recall classifications, appears in 21 CFR Part 7. For food, section 423 of the Federal Food, Drug, and Cosmetic Act, added by the Food Safety Modernization Act, gives FDA mandatory-recall authority in specified circumstances; that authority is distinct from a company's voluntary recall.

FDA explains that public notification is generally used for widely distributed products or serious hazards, and that not every recall appears on its website or in news coverage. Its consumer guide to drug recalls sets out the three risk classes and tells consumers not to stop a medicine without talking to a health professional first.

For verification, check the issuer's own record. FDA's Enforcement Report lists recall entries, while MedWatch is FDA's safety-information and adverse-event reporting program. CDC's Health Alert Network (HAN) distributes public-health alerts; it is not an FDA recall record.

Other US issuers include CDC, USDA's Food Safety and Inspection Service (FSIS), the Consumer Product Safety Commission (CPSC) and state health departments, such as the California Department of Public Health and the New York State Department of Health. For international notices, check WHO Disease Outbreak News, EMA safety communications, the UK's MHRA Drug Safety Update and Health Canada's Recalls and Safety Alerts. Match the issuer to the product and jurisdiction before describing the notice.

FDA's recalls of some valsartan medicines after NDMA was found in certain products provide a concrete example. Identify the affected product and lot from the notice rather than implying every valsartan product is included.

Visibility is not classification. A recall notice is also not a licence for a newsroom to issue its own treatment advice.

Keep the audiences apart

A clinician's monitoring instruction rewritten as a patient order changes who is being told to do what.

Use labeled sections: for people using the product, for clinicians, for facilities. Keep every condition attached to testing, monitoring or treatment. Drop the condition and the sentence becomes an instruction.

Stale advice outlives the article

Adding a final paragraph after an agency changes the affected area leaves the old headline in search results and social cards.

Replace superseded instructions in the headline, the summary, the action line, the captions and the body. Add a dated note explaining what changed. Keep the earlier version in the editorial record without leaving the harmful line where readers land.

Safe and dangerous are not labels you assign

Absence of confirmed cases is not "safe". Detection in one setting is not "dangerous everywhere".

Tie each statement to evidence, population, place and time. Say what officials have found and what they have not. Describe the protective action without promising zero risk.

Common questions

Is "linked to" a causal phrase?

It can read as one. Explain what the link rests on, whether that is epidemiology, traceback, laboratory testing or a regulator's finding. If the basis is sequence alone, say so.

Can a newsroom tell readers to stop a prescription?

Only by repeating a qualified instruction from the responsible authority. Many recall notices direct patients to contact a health professional first, and that condition travels with the instruction.

Is a large relative increase always important?

No. The reader needs the baseline, the absolute difference, the outcome measured, the follow-up period and the uncertainty around it. Without those, the percentage is unreadable.

What gets corrected first when advice changes?

Any sentence that controls reader action, then the headline, the summary, the product box and the distribution text. Those are the surfaces readers see before they see the correction.